ACHV: Achieve Life Sciences, Inc Earnings per share for the last twelve months

Achieve Life Sciences Inc. (ACHV) - corporate logo

Achieve Life Sciences relies on external contractors for the synthesis of nicotine addiction medications. This TTM earnings per share chart illustrates financial dynamics, where the current mark is -1.55. While the robotization of molecule screening accelerates product development, business success depends on FDA approval and market demand for addiction treatment tools.

ACHV (Achieve Life Sciences Inc) Net earnings per share (EPS TTM) history from 07/04/2022 to 11/10/2026

Analytical breakdowns for Achieve Life Sciences, Inc (ACHV)

- current quotes and average value forecast:
Fundamental company analysis:Achieve Life Sciences Inc (ACHV)
Manufactured products of Achieve Life Sciences Inc.

This indicator is calculated as the ratio of the company's total net income to the total number of outstanding shares per year. The net income per share trend over the last four quarters filters out market noise, allowing for an assessment of how the robotization of laboratory screenings impacts the cost efficiency of Achieve Life Sciences (ACHV) and the overall fundamental stability of its capital.